Shares of Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) rose 0.1% during trading on Thursday . The company traded as high as $0.3208 and last traded at $0.3208. 292 shares changed hands during trading, a decline of 97% from the average daily volume of 9,624 shares. The stock had previously closed at $0.3206.
Algernon Pharmaceuticals Stock Up 0.1%
The business’s 50 day moving average is $0.31 and its two-hundred day moving average is $0.14.
Algernon Pharmaceuticals Company Profile
Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.
The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).
Read More
- Five stocks we like better than Algernon Pharmaceuticals
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
